Relevance or performance: potential savings associated with verification of prior results before performing microbiology analysis
| Autor: | Annie-Claude Labbé, Georges Ambaraghassi, Christian Lavallée, Claire Béliveau |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
0301 basic medicine
Microbiology (medical) Repeat testing business.industry Clinical Laboratory Techniques 030106 microbiology General Medicine Unnecessary Procedures medicine.disease Rubella HCV Antibody Cost savings Microbiology 03 medical and health sciences 0302 clinical medicine Infectious Diseases Cost Savings Toxin detection Medicine Humans 030212 general & internal medicine business Clinical Laboratory Information Systems Clostridioides |
| Zdroj: | Diagnostic microbiology and infectious disease. 93(2) |
| ISSN: | 1879-0070 |
| Popis: | Objective In an era of rising healthcare expenditures, it is critical to find ways to decrease cost. The objective of this study is to evaluate the number of repeated tests and the associated cost savings in a university-affiliated hospital. Methods The following 7 microbiology analysis were assessed for nonrepeat testing: HCV antibody, HBV core antibody, CMV IgG, rubella IgG, Treponema pallidum antibodies, Clostridioides difficile toxin detection, and vancomycin-resistant enterococci PCR. Presence of a prior positive result leads to the cancellation of subsequent orders. Results Percentages of not repeated test ranged from 0.1% to 21.4%. Rubella IgG had the highest proportion of unnecessary repeat testing. Total cost savings were estimated at $33,627 for 2016. Conclusion Unnecessary repeated microbiologic test can account for a non-negligible part of total volume test. Use of an automated software to detect unnecessary repeated microbiologic test through laboratory information system can generate important savings. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect